Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Open: Feb 9, 16:14 PM 2012 
  NYSE  8083.11  0.13  Index Moved Up   NASDAQ  2927.23  11.37  Index Moved Up 
 and more..
Search
sponsered by
  
  



Processing
Collecting necessary data for ALKS and FLML...
    
  Alkermes Inc.  and    Flamel Technologies S.A.
        
    
Diversification
Average diversification
Overlapping area represents amount of risk that can be diversified away by holding Alkermes Inc. and Flamel Technologies S.A. in the same portfolio (assuming nothing else is changed)
    
    
Correlation Coefficient
0.11
 Parameters
Time Period1 Month [change]
DirectionPositive FLML Moved Up vs ALKS
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns
    
    

       

Alkermes Inc.

    
    
18.45
  
Alkermes Quote
Intraday
 
Alkermes Intraday Quote
One Month
(0.43)  Macroaxis: -2.28 Down   2.28%  
ALKS Macroaxis: United States NASDAQAlkermes Quote: Bear
Alkermes Inc.
Day Low18.44Open19.04
P/B Ratio2.71Market Cap2.394B
Volume547119SectorHealthcare
Last Close18.88FoundedYes
Short Ratio7.60Last Traded2/9/2012
Year High20.00Percent ChangePrice Moved Very Down 2.28%
EBITDA12.2MYear Low11.86
Absolute Change0.43 Price Moved DownTimeNot Applicable
Book Value6.974EPS-0.60
PEG Ratio0.13Employees600
Day High19.05IndustryDrug Delivery
Target Price21.90Current EPS-0.60
This Year EPS-0.62Next Year EPS-0.28
  

Flamel Technologies S.A.

    
    
6.65
  
Flamel Quote
Intraday
 
Flamel Intraday Quote
One Month
 0.07   Macroaxis: 1.06 Up   1.06%  
FLML Macroaxis: United States NGMFlamel Quote: Bull
Flamel Technologies S.A.
Day Low6.575Open6.68
P/B Ratio5.01Market Cap163.9M
Volume79805SectorHealthcare
Last Close6.58FoundedYes
Short Ratio1.00Last Traded2/9/2012
Year High7.35Percent ChangePrice Moved Up 1.06%
EBITDA-1.4MYear Low3.61
Absolute Change0.07 Price Moved UpTimeNot Applicable
Book Value1.313EPS-0.162
PEG Ratio0.20Employees291
Day High6.69IndustryDrug Delivery
Target Price12.00Current EPS-0.162
This Year EPS-0.17Next Year EPS0.51
Next Year PE12.90DividendNot Applicable